保和丸於胰臟惡性腫瘤末期運用之病例探討

Treatment of Advanced Pancreatic Carcinoma Patients with Baohe Pills: A Case Report

廖翊芳(Yi-Fang Liao) ； 陳金女(Chin-Nu Chen) ； 賴榮年(Jung-Nien Lai)

《中醫藥研究論叢》 20卷2期 (2017/09) Pp. 149-155

https://doi.org/10.6516/TJTCM.2017.20(2)149

摘要

胰臟惡性腫瘤的61 歲女性，分析其癌症末期死亡前318 天的就診用藥，接受中西醫合併治療共58 日，在病患腎絲球過濾率下降到69 的時候，服用39 天的保和丸共248 公克，腎絲球過濾率上升到96。顯示中西藥併用不但沒有腎臟毒性的交互作用，而且保和丸在胰臟癌末期可能具有保護腎絲球免於損害的保護作用，結論：胰臟惡性腫瘤末期的病患如果腸胃功能不好、食慾不振，保和丸為一安全可以搭配併服用的中藥方劑。

關鍵字

保和丸 ； 胰臟惡性腫瘤 ； 腎絲球過濾率

並列摘要

We would like to report for what TCM practitioners may experience as a 61-year-old female patient goes through the end stages of pancreatic cancer. The retrospective chart was reviewed and we found that she received 58-day traditional Chinese herbal products in 318-day medical record before her death. Interestingly, her estimated glomerular filtration rate (eGFR) was from 69 mL/ min/1.73 m^2 to 96 mL/min/1.73 m^2 after taking 248-gram of Baohe pills (totally 39 days). This result infers that Baohe pills might be a safe choice in treating gastrointestinal upset for pancreatic patient who were receiving nephrotoxic chemotherapeutic regimen.

並列關鍵字

Baohe pills ； Pancreatic cancer ； Glomerular Filtration Rate

參考文獻

Niederhuber, John E.,Brennan, Murray F.,Menck, Herman R.(1995).The National Cancer Data Base Report on Pancreatic Cancer.Cancer.76(9),1671-1677.

陳苓怡、郭美娟、黃尚志、蔡哲嘉、陳鴻鈞(2012)。臨床評估腎臟功能方法之優缺點。內科學誌。23，34-41。

吳明儒(2007)。評估腎臟功能的方法。腎臟與透析。19(2)，45-49。

Guchelaar, H-J.,Richelt, D. J.,van Knapen A(1996).Clinical, toxicological and pharmacological aspects of gemcitabine.Cancer Treatment Reviews.22,15-31.

YE, LIN,JIA, YONGNING,JI, KE,SANDERS, ANDREW J.,XUE, KAN,JI, JIAFU,MASON, MALCOLM D.,JIANG, WEN G.(2015).Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.ONCOLOGY LETTERS..1240-1250.